ianian ian kyle friedreich’s ataxia pfizer rare disease ... · pfizer rare disease is committed...

9
Pfizer Rare Disease here to listen, learn and make a difference Michael Duchenne Muscular Dystrophy Amelia Growth Hormone Deficiency Kyle Sickle Cell Disease Ian Growth Hormone Deficiency Kyle Friedreich’s Ataxia Carolyn Acromegaly Curt Hemophilia B Amiya Sickle Cell Disease Gary TTR-FAP Emily Cystic Fibrosis Amy Growth Hormone Deficiency Michael Duchenne Muscular Dystrophy Amelia Growth Hormone Deficiency Kyle Sickle Cell Disease Susan Acromegaly Tiahna Sickle Cell Disease Ian Growth Hormone Deficiency Kyle Friedreich’s Ataxia Cyndi Gaucher Disease Carolyn Acromegaly Matt Friedreich’s Ataxia Curt Hemophilia B Gabe Hemophilia A Amiya Sickle Cell Disease Gary TTR-FAP David TTR-FAP Confidential. Internal Use Only. Amy Growth Hormone Deficiency Michael Duchenne Muscular Dystrophy Amelia Growth Hormone Deficiency Kyle Sickle Cell Disease Susan Acromegaly Tiahna Sickle Cell Disease Ian Growth Hormone Deficiency Kyle Friedreich’s Ataxia Cyndi Gaucher Disease Carolyn Acromegaly Matt Friedreich’s Ataxia Curt Hemophilia B Gabe Hemophilia A Amiya Sickle Cell Disease Gary TTR-FAP David TTR-FAP 1 Sonal Bhatia, MD Vice President North America Rare Disease Medical Affairs Lead February 13, 2018

Upload: others

Post on 31-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

Pfizer Rare Disease here to listen, learn and make a difference

Michael

Duchenne Muscular Dystrophy

Amelia

Growth Hormone Deficiency Kyle

Sickle Cell Disease

Ian

Growth Hormone Deficiency Kyle

Friedreich’s Ataxia

Carolyn

Acromegaly

Curt

Hemophilia B

Amiya

Sickle Cell Disease

Gary

TTR-FAP

Emily

Cystic Fibrosis

Amy

Growth Hormone Deficiency Michael

Duchenne Muscular Dystrophy

Amelia

Growth Hormone Deficiency Kyle

Sickle Cell Disease

Susan

Acromegaly

Tiahna

Sickle Cell Disease

Ian

Growth Hormone Deficiency Kyle

Friedreich’s Ataxia

Cyndi

Gaucher Disease

Carolyn

Acromegaly

Matt

Friedreich’s Ataxia

Curt

Hemophilia B

Gabe

Hemophilia A Amiya

Sickle Cell Disease

Gary

TTR-FAP

David

TTR-FAP

Confidential. Internal Use Only.

Amy

Growth Hormone Deficiency Michael

Duchenne Muscular Dystrophy

Amelia

Growth Hormone Deficiency Kyle

Sickle Cell Disease

Susan

Acromegaly

Tiahna

Sickle Cell Disease

Ian

Growth Hormone Deficiency Kyle

Friedreich’s Ataxia

Cyndi

Gaucher Disease

Carolyn

Acromegaly

Matt

Friedreich’s Ataxia

Curt

Hemophilia B

Gabe

Hemophilia A Amiya

Sickle Cell Disease

Gary

TTR-FAP

David

TTR-FAP

1

Sonal Bhatia, MD

Vice President

North America Rare Disease Medical Affairs Lead

February 13, 2018

Page 2: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

• Global footprint & investment

• Around 70 scientists working to find

treatments

• Over 20 compounds in pre-clinical and

clinical development

• Late-stage pipeline opportunities

• Investigational one time gene therapy

treatments

Our Commitment

Michael | DMD Amiya | SCD

Scientists | Pfizer

2

Page 3: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

3

Pfizer’s Global Rare Disease Portfolio*

Page 4: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

Approximately 300,000 infants worldwide are born each year with sickle cell disease

1. Piel FB, et al. NEJM. 2017;376:1561-1573. 2. Hassell KL. Am J Prev Med. 2010;38(4S):S512-S521. 3. SicklecellNA.org.2017

Sickle Cell Disease (SCD): The Global Presence

4

~100,000 Americans have SCD and 2% to 10% are Hispanic (~2,500–10,000)

~2 million Americans are carriers of the sick cell trait

Page 5: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

5

SCD patient in VOC

presents in ED Subject receives supportive

care (IV hydration, opioids)

from ER assessment to

discharge

Pivotal Phase 3 study in patients with SCD experiencing Vaso-Occlusive Crisis (VOC)

• N=350, randomized, double blind, placebo controlled; approximately 70 centers US & Canada

• Study population: 6 years of age; VOC requiring hospitalization

• Primary Endpoint: Readiness for discharge

• Secondary Endpoints: Time to stopping IV opioids; cumulative IV opioid consumption

Open-label extension study

• N=150

• Study population: Subjects who complete the double-blind study and meet other qualification criteria

• Objective: Evaluate the safety of rivipansel when used to treat >1 episode of VOC.

Safety follow-

up 35-day

post last dose

Placebo

Rivipansel DIS

CH

AR

GE

DE

CIS

ION

TO

AD

MIT

1:1

RA

ND

OM

IZA

TIO

N

Open Label

Study

Phase 3 Program

Page 6: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

Empowers Patients to Self Advocate thereby Elevating the Care Paradigm

rareCourage Social Wall

Integrating vetted disease content into members’ conversations

Curation Working Group Guides curation of credible content to address knowledge gaps

Community Managers Engages patients & advocates to utilize oneSCDvoice by providing tips & timely connections to content

rareCurate Knowledge

Access to vetted disease content

Engagement Working Group Drives awareness & connectivity to patients engaging local advocacy networks

Platform Developed With The Community and For The Community

rareClinical trials

Education for drug development and diversity in clinical trials

6

Harmonizing and Empowering a Fragmented Patient Community

Page 7: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

7

Partner Organizations

Pfizer collaborates with many groups and organizations both through and beyond

“Council For Change”

Page 8: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

Pfizer Rare Disease here to listen, learn and make a difference

Michael

Duchenne Muscular Dystrophy

Amelia

Growth Hormone Deficiency Kyle

Sickle Cell Disease

Ian

Growth Hormone Deficiency Kyle

Friedreich’s Ataxia

Carolyn

Acromegaly

Curt

Hemophilia B

Amiya

Sickle Cell Disease

Gary

TTR-FAP

Emily

Cystic Fibrosis

Amy

Growth Hormone Deficiency Michael

Duchenne Muscular Dystrophy

Amelia

Growth Hormone Deficiency Kyle

Sickle Cell Disease

Susan

Acromegaly

Tiahna

Sickle Cell Disease

Ian

Growth Hormone Deficiency Kyle

Friedreich’s Ataxia

Cyndi

Gaucher Disease

Carolyn

Acromegaly

Matt

Friedreich’s Ataxia

Curt

Hemophilia B

Gabe

Hemophilia A Amiya

Sickle Cell Disease

Gary

TTR-FAP

David

TTR-FAP

Confidential. Internal Use Only.

Amy

Growth Hormone Deficiency Michael

Duchenne Muscular Dystrophy

Amelia

Growth Hormone Deficiency Kyle

Sickle Cell Disease

Susan

Acromegaly

Tiahna

Sickle Cell Disease

Ian

Growth Hormone Deficiency Kyle

Friedreich’s Ataxia

Cyndi

Gaucher Disease

Carolyn

Acromegaly

Matt

Friedreich’s Ataxia

Curt

Hemophilia B

Gabe

Hemophilia A Amiya

Sickle Cell Disease

Gary

TTR-FAP

David

TTR-FAP

Pfizer Rare Disease is committed to transforming the lives of the

rare disease community through life-changing innovations,

trusted partnerships, and relentless passion. 8

Page 9: IanIan Ian Kyle Friedreich’s Ataxia Pfizer Rare Disease ... · Pfizer Rare Disease is committed to transforming the lives of the rare disease community through life-changing innovations,

Pfizer Rare Disease Time to seize the moment! We have been here, we are

here and we will be here for

the Rare Disease community.